Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting vs. zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis (RESTENT-ISR trial)

• Published in: European heart journal Vol. 37; no. 45; pp. 3409 - 3418
• Main Authors: Hong, Soon Jun, Ahn, Chul Min, Kim, Byeong-Keuk, Ko, Young-Guk, Hur, Seung-Ho, Yu, Cheol Woong, Lee, Seung-Jin, Choi, Cheol Ung, Kim, Je Sang, Yoon, Jung-Han, Hong, Young Joon, Choi, Jae-Woong, Choi, Seung-Hyuk, Jang, Yangsoo, Lim, Do-Sun
• Format: Journal Article
• Language: English
• Published: England 01.12.2016
• Subjects: Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus - analogs & derivatives; Treatment Outcome; Restenosis; Zotarolimus; Neointima; Everolimus

At present no proven standard treatment for drug-eluting stent (DES) restenosis is available, and the efficacy and safety of everolimus-eluting stent (EES) and zotarolimus-eluting stent (ZES) for DES restenosis are limited. The purpose of this prospective, randomized 9-month intracoronary ultrasound...